With offices in Shenzhen, Beijing, Suzhou, and Chicago, Sangel Capital brings together a team of industry experts, scientists, and investors to manage RMB and USD funds. As one of the earliest professional biomedical venture capital institutions in China, Sangel Capital focuses on the life science and technology field, and has a leading professional advantage and abundant project resources in the domestic biomedical investment area. Sangel Capital invests in innovative growth enterprises with great capital value and commercial potential, and trains a number of industry benchmarks.